Back to Screener

Healthcare

Iovance Biotherapeutics, Inc.(IOVA)

Live Price

Offline

$4.21

-0.94% today

1Y Change

+141.95%

Window

Jun 26, 2025 β†’ Jun 25, 2026

Market Cap
$1.11B
Revenue Growth
+60.6%
EPS Growth
+14.8%
Dividend Yield
0.0%

Coverage: 250 bars Β· Jun 26, 2025 β†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Iovance Biotherapeutics, Inc. (IOVA) is a Healthcare stock with a market cap of $1.11B and listed on NASDAQ. The stock last traded around $4.21 and up 142.0% across the available one-year price window (Jun 26, 2025 β†’ Jun 25, 2026). Baseline metrics include revenue growth of +60.6%, EPS growth of +14.8%, a dividend yield of 0.0%. What stands out right now is revenue +60.6%, EPS +14.8%, free cash flow +7.6% with operating margin -153.1% and ROIC -51.5%. Valuation sits in the middle of the pack at price/sales 4.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IOVA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IOVA vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IOVA

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IOVA Max Drawdown

-54.41%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IOVA and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
May 14, 26
β€”
Est -0.17
β€”
β€”
Est 82551.4B
β€”
May 14
β€”
Feb 24, 26
βœ“
-0.18
Est -0.22
+18.2%
86711.0B
Est 80707.1B
+7.4%
Feb 24
β€”
Nov 6, 25
βœ“
-0.25
Est -0.29
+13.8%
67455.0B
Est 82168.9B
-17.9%
Nov 6
β€”
Aug 7, 25
βœ—
-0.33
Est -0.29
-13.8%
59952.0B
Est 78321.4B
-23.4%
Aug 7
β€”
May 8, 25
βœ—
-0.36
Est -0.25
-44.0%
49324.0B
Est 82374.2B
-40.1%
May 8
β€”
Feb 27, 25
β€”
-0.26
Est -0.26
0.0%
73694.0B
Est 72174.1B
+2.1%
Feb 27
β€”
Nov 7, 24
βœ“
-0.28
Est -0.31
+9.7%
58554.0B
Est 71570.3B
-18.2%
Nov 7
β€”
Aug 8, 24
βœ“
-0.34
Est -0.37
+8.1%
31106.0B
Est 24590.0B
+26.5%
Aug 8
β€”
May 9, 24
βœ“
-0.42
Est -0.45
+6.7%
715.0B
Est 2070.0B
-65.5%
May 9
β€”
Feb 28, 24
βœ—
-0.45
Est -0.44
-2.3%
482.0B
Est 1390.0B
-65.3%
Feb 28
β€”
Nov 7, 23
β€”
-0.46
Est -0.46
0.0%
469.0B
Est 1720.0B
-72.7%
Nov 7
β€”
Aug 8, 23
βœ“
-0.47
Est -0.81
+42.0%
238.0B
Est 3580.0B
-93.3%
Aug 8
β€”
May 9, 23
βœ“
-0.50
Est -0.84
+40.5%
β€”
Est 200.0B
β€”
May 9
β€”
Feb 28, 23
β€”
-0.64
Est -0.64
0.0%
β€”
Est β€”
β€”
Feb 28
β€”
Nov 3, 22
βœ“
-0.63
Est -0.64
+1.6%
β€”
Est β€”
β€”
Nov 3
β€”
Aug 4, 22
βœ—
-0.63
Est -0.60
-5.0%
β€”
Est β€”
β€”
Aug 4
β€”
May 5, 22
βœ“
-0.58
Est -0.64
+9.4%
β€”
Est β€”
β€”
May 5
β€”
Feb 24, 22
βœ—
-0.63
Est -0.56
-12.5%
β€”
Est β€”
β€”
Feb 24
β€”
Nov 4, 21
βœ—
-0.55
Est -0.52
-5.8%
β€”
Est β€”
β€”
Nov 4
β€”
Aug 5, 21
βœ—
-0.53
Est -0.52
-1.9%
β€”
Est β€”
β€”
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener